RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
  Constipation
  GERD
  IBS
  Inflammatory Bowel Disease
  Liver
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Jan 9, 2010 - 5:55:44 PM
Research Article
Gastroenterology Channel

subscribe to Gastroenterology newsletter
Latest Research : Gastroenterology

   EMAIL   |   PRINT
Integrins act as receptors to Rotavirus

Jun 30, 2008 - 9:07:20 AM , Reviewed by: Dr. Sanjukta Acharya
"It's a new ligand for binding to integrins," Dr. Mary Estes of Baylor College of Medicine said. "It begins to give us an understanding of how the enterotoxin works in the intestine."

 
[RxPG] Eleven years ago, Dr. Mary Estes of Baylor College of Medicine and her colleagues discovered the first viral enterotoxin, rotavirus NSP4, a toxic protein that affects the intestines, causing diarrhoea.

The next step was to find the cellular receptor on intestinal cells through which the enterotoxin interacts to cause diarrhoea.

"We knew that identifying the receptor might not be straightforward," said the professor of molecular virology and microbiology at BCM. In a report online in the Proceedings of the National Academy of Sciences, Estes and her colleagues describe two receptors for the enterotoxin, both of them integrins.

The two, integrin alpha1 beta1 and integrin alpha2 beta1, are members of a class of molecules that are involved in attaching cells to other cells and to the extracellular matrix (a part of tissue that is not part of any cell). Integrins also are involved in transforming or translating cell signals.

In looking for the receptor, Estes and her colleagues also learned more about the enterotoxin itself.

"It's a new ligand for binding to integrins," she said. "It begins to give us an understanding of how the enterotoxin works in the intestine. Two different domains of the enterotoxin are involved in this interaction. One domain is for binding and the other domain is for signaling through the receptor."

She said she hopes to study the signaling aspect of the enterotoxin more closely because it could hold the clue to the mechanism of induction of diarrhoeal disease.

"There may be ways to block the interaction between the enterotoxin and the receptor to treat diarrhoeal disease," said Estes, who is also director of the Texas Medical Center Digestive Diseases Center.

Rotavirus is one of the most common causes of diarrhoea, resulting in approximately 3 million cases of diarrhoea and 55,000 hospitalizations for diarrhoea and dehydration in children under the age of 5 each year in the United States alone. Worldwide, it causes nearly half a million deaths each year. Finding out how rotavirus causes diarrhoea and looking for ways to block it is a major aim of Estes' research.





Funding information and declaration of competing interests: Funding for this work came from the National Institutes of Health, including a grant that funds the Texas Medical Center Digestive Diseases Center.

Related Gastroenterology News
Weight loss by targeting satiety hormone
Mayo Clinic studies how much practice makes perfect when performing colonoscopies
Attacking bowel cancer on 2 fronts
New gene sites affecting nonalcoholic fatty liver disease discovered
New vaccine technology protects mice from hepatitis C virus
Y-90 radioembolization offers promise for late-stage liver cancer
Gastric bypass alters sweet taste function
Liver hormone is a cause of insulin resistance
Increased mortality risk in later years in obese children following Liver transplantation
NC Children's Hospital part of $12 million grant to create first-of-kind registry for IBD

Subscribe to Gastroenterology Newsletter

Enter your email address:


 About Dr. Sanjukta Acharya
This news story has been reviewed by Dr. Sanjukta Acharya before its publication on RxPG News website. Dr. Sanjukta Acharya, MBBS MRCP is the chief editor for RxPG News website. She oversees all the medical news submissions and manages the medicine section of the website. She has a special interest in diabetes and endocrinology. She can be reached for corrections and feedback at sanjukta.acharya@rxpgnews.com
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Additional information about the news article
Others who took part in this work include Carl Q.-Y. Zeng, Joseph M. Hyser, Budi Utama and Sue E. Crawford of BCM, Neung-Seon Seo, Kate J. Kim and Magnus Hõõk of Texas A&M University Health Science Center at Houston.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

All rights reserved by RxPG
Contact Us